These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16954466)

  • 61. A new partner for the international knockout mouse consortium.
    Collins FS; Finnell RH; Rossant J; Wurst W
    Cell; 2007 Apr; 129(2):235. PubMed ID: 17448981
    [No Abstract]   [Full Text] [Related]  

  • 62. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effectiveness of 17DMAG, a geldanamycin derivative, in murine acute myeloid leukemia.
    Panarsky R; Reichert F; Ben-Ishay Z
    Acta Haematol; 2009; 121(1):32-6. PubMed ID: 19332984
    [No Abstract]   [Full Text] [Related]  

  • 64. Cancer: off by a whisker.
    Dennis C
    Nature; 2006 Aug; 442(7104):739-41. PubMed ID: 16915261
    [No Abstract]   [Full Text] [Related]  

  • 65. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
    Mennuni C; Ugel S; Mori F; Cipriani B; Iezzi M; Pannellini T; Lazzaro D; Ciliberto G; La Monica N; Zanovello P; Bronte V; Scarselli E
    Cancer Res; 2008 Dec; 68(23):9865-74. PubMed ID: 19047167
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The chakragati mouse: a mouse model for rapid in vivo screening of antipsychotic drug candidates.
    Dawe GS; Ratty AK
    Biotechnol J; 2007 Nov; 2(11):1344-52. PubMed ID: 17886239
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emerging role of new transgenic mouse models in glioma research.
    Sonabend AM; Ulasov IV; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Progress reported on mouse models for AIDS.
    Marx JL
    Science; 1988 Dec; 242(4886):1638. PubMed ID: 3059496
    [No Abstract]   [Full Text] [Related]  

  • 70. Hidden sacrifice: for every transgenic mouse, tens more are consigned to an early grave.
    Coghlan A
    New Sci; 1999 May; 162(2185):4. PubMed ID: 12186097
    [No Abstract]   [Full Text] [Related]  

  • 71. Making the most of transgenic mice.
    Nat Neurosci; 1998 Oct; 1(6):429. PubMed ID: 10196535
    [No Abstract]   [Full Text] [Related]  

  • 72. A home for the mighty mouse.
    Culliton BJ
    Nature; 1993 Aug; 364(6440):755. PubMed ID: 8355800
    [No Abstract]   [Full Text] [Related]  

  • 73. Down on the organ farm. New hope that animals could one day shorten the wait for a transplant.
    Boyce N
    US News World Rep; 2003 Jun; 134(21):47-8. PubMed ID: 12858624
    [No Abstract]   [Full Text] [Related]  

  • 74. Mouse Models of Human Cancers Consortium (MMHCC) from the NCI.
    Marks C
    Dis Model Mech; 2009; 2(3-4):111. PubMed ID: 19259381
    [No Abstract]   [Full Text] [Related]  

  • 75. Managing a mouse mutant resource center...this is not your father's transgenic core.
    Garrett-Beal LJ; Hoogstraten SL
    Lab Anim (NY); 2003 Sep; 32(8):31-7. PubMed ID: 12966446
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Building a better mouse.
    BeSaw L
    Tex Med; 1996 Aug; 92(8):40-3. PubMed ID: 8772374
    [No Abstract]   [Full Text] [Related]  

  • 77. Message from a mouse: it takes more than genes to make a smart rodent, or high-IQ humans.
    Gould SJ
    Time; 1999 Sep; 154(11):62. PubMed ID: 10620922
    [No Abstract]   [Full Text] [Related]  

  • 78. From the National Institutes of Health.
    Kirschstein R
    JAMA; 1993 Sep; 270(10):1172. PubMed ID: 8355369
    [No Abstract]   [Full Text] [Related]  

  • 79. Gene targeting comes to top-down drug screens.
    Sedivy JM
    Trends Biotechnol; 2002 Mar; 20(3):92-3. PubMed ID: 11841852
    [No Abstract]   [Full Text] [Related]  

  • 80. In defense of cell-line screening.
    Chabner BA
    J Natl Cancer Inst; 1990 Jul; 82(13):1083-5. PubMed ID: 2359129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.